4//SEC Filing
Tak Paul Peter 4
Accession 0001209191-22-060689
CIK 0001841387other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:25 PM ET
Size
7.2 KB
Accession
0001209191-22-060689
Insider Transaction Report
Form 4
Tak Paul Peter
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-12-08$1.70/sh+3,050$5,185→ 28,050 total - Purchase
Common Stock
2022-12-09$1.92/sh+12,935$24,835→ 40,985 total
Footnotes (2)
- [F1]The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.89 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873905
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 4:25 PM ET
- Size
- 7.2 KB